Susceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phases

Journal of Prosthodontic Research

Volumn 59, Issue 1, 2015, Pages 42-48

  Monteiro, Douglas Roberto ^a   Takamiya, Aline Satie ^a   Feresin, Leonardo Perina ^a   Gorup, Luiz Fernando ^b   de Camargo, Emerson Rodrigues ^b   Delbem, Alberto Carlos Botazzo ^a   Henriques, Mariana ^c   Barbosa, Debora Barros ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Biofilms; Candida albicans; Candida glabrata; Denture stomatitis; Silver nanoparticles

Indexed keywords

METAL NANOPARTICLE; SILVER DERIVATIVE;

ANTIFUNGAL RESISTANCE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; SYNTHESIS;

BIOFILMS; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG RESISTANCE, FUNGAL; METAL NANOPARTICLES; SILVER COMPOUNDS;

EID: 84920714293     PISSN: 18831958     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpor.2014.07.004     Document Type: Article

References (31)

1. Budtz-Jorgensen E., Bertram U. Denture stomatitis. I. The etiology in relation to trauma and infection. Acta Odontol Scand 1970, 28:71-92.
2. Redding S., Bhatt B., Rawls H.R., Siegel G., Scott K., Lopez-Ribot J. Inhibition of Candida albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:669-672.
3. Samaranayake L.P., Keung Leung W., Jin L. Oral mucosal fungal infections. Periodontol 2000 2009, 49:39-59.
4. Coco B.J., Bagg J., Cross L.J., Jose A., Cross J., Ramage G. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. Oral Microbiol Immunol 2008, 23:377-383.
5. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001, 183:5385-5394.
6. Nett J.E., Marchillo K., Spiegel C.A., Andes D.R. Development and validation of an in vivo Candida albicans biofilm denture model. Infect Immun 2010, 78:3650-3659.
7. Chandra J., Mukherjee P.K., Leidich S.D., Faddoul F.F., Hoyer L.L., Douglas L.J., et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001, 80:903-908.
8. Sardi J.C., Scorzoni L., Bernardi T., Fusco-Almeida A.M., Mendes Giannini M.J. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013, 62:10-24.
9. Lamfon H., Porter S.R., McCullough M., Pratten J. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 2004, 53:383-385.
10. Shen Y., Stojicic S., Haapasalo M. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development. J Endod 2011, 37:657-661.
11. Nett J.E., Sanchez H., Cain M.T., Ross K.M., Andes D.R. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell 2011, 10:1660-1669.
12. Monteiro D.R., Gorup L.F., Silva S., Negri M., de Camargo E.R., Oliveira R., et al. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata. Biofouling 2011, 27:711-719.
13. Monteiro D.R., Gorup L.F., Takamiya A.S., de Camargo E.R., Filho A.C., Barbosa D.B. Silver distribution and release from an antimicrobial denture base resin containing silver colloidal nanoparticles. J Prosthodont 2012, 21:7-15.
14. Monteiro D.R., Silva S., Negri M., Gorup L.F., de Camargo E.R., Oliveira R., et al. Silver nanoparticles: influence of stabilizing agent and diameter on antifungal activity against Candida albicans and Candida glabrata biofilms. Lett Appl Microbiol 2012, 54:383-391.
15. Silva S., Pires P., Monteiro D.R., Negri M., Gorup L.F., Camargo E.R., et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. Med Mycol 2013, 51:178-184.
16. Monteiro D.R., Silva S., Negri M., Gorup L.F., de Camargo E.R., Oliveira R., et al. Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms. J Appl Microbiol 2013, 114:1175-1183.
17. Monteiro D.R., Silva S., Negri M., Gorup L.F., de Camargo E.R., Oliveira R., et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. Mycoses 2013, 56:672-680.
18. Costa C.S., Ronconi J.V., Daufenbach J.F., Gonçalves C.L., Rezin G.T., Streck E.L., et al. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem 2010, 342:51-56.
19. Kim K.J., Sung W.S., Suh B.K., Moon S.K., Choi J.S., Kim J.G., et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009, 22:235-242.
20. Lok C.N., Ho C.M., Chen R., He Q.Y., Yu W.Y., Sun H., et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 2006, 5:916-924.
21. Rai M., Yadav A., Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009, 27:76-83.
22. Gorup L.F., Longo E., Leite E.R., Camargo E.R. Moderating effect of ammonia on particle growth and stability of quasi-monodisperse silver nanoparticles synthesized by the Turkevich method. J Colloid Interface Sci 2011, 360:355-358.
23. LaFleur M.D., Kumamoto C.A., Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006, 50:3839-3846.
24. Anwar H., Strap J.L., Costerton J.W. Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin. Can J Microbiol 1992, 38:618-625.
25. Seneviratne C.J., Silva W.J., Jin L.J., Samaranayake Y.H., Samaranayake L.P. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009, 54:1052-1060.
26. Kalishwaralal K., BarathManiKanth S., Pandian S.R., Deepak V., Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 2010, 79:340-344.
27. Fonseca E., Silva S., Rodrigues C.F., Alves C.T., Azeredo J., Henriques M. Effects of fluconazole on Candida glabrata biofilms and its relationship with ABC transporter gene expression. Biofouling 2014, 30:447-457.
28. Tobudic S., Kratzer C., Lassnigg A., Graninger W., Presterl E. In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother 2010, 65:271-274.
29. Vandenbosch D., Braeckmans K., Nelis H.J., Coenye T. Fungicidal activity of miconazole against Candida spp. biofilms. J Antimicrob Chemother 2010, 65:694-700.
30. Nikawa H., Hamada T., Yamashiro H., Kumagai H. A review of in vitro and in vivo methods to evaluate the efficacy of denture cleansers. Int J Prosthodont 1999, 12:153-159.
31. Silva-Lovato C.H., Wever B., Adriaens E., Paranhos H.F., Watanabe E., Pisani M.X., et al. Clinical and antimicrobial efficacy of NitrAdine™-based disinfecting cleaning tablets in complete denture wearers. J Appl Oral Sci 2010, 18:560-565.